Trials / Completed
CompletedNCT04125199
Effects of Decohexaenoic Acid Supplementation on Markers of Inflammatory Muscle Damage
Effects of Decohexaenoic Acid Supplementation on Markers of Inflammatory Muscle Damage Induced by Eccentric Exercise in Endurance Athletes
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Universidad Católica San Antonio de Murcia · Academic / Other
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Randomized, placebo-controlled, double-blind, placebo-controlled clinical trial consisting of 15 triathletes in which it is intended to observe less inflammatory damage at the muscular level after performing eccentric exercises.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | supplement consumption | Composition of the Experimental Product: Concentrated oil of Tridocosahexaenoin-AOX® \* (350 mg per capsule), α-tocopherol and coating agent (gelatin). Each capsule is 700 mg, of which 500 mg is oil. Placebo composition: Olive oil (each capsule is 700 mg). Number of capsules: 6 per day, for any of the two products. The dose taken daily is 2.1 g / day for DHA. Supplementation Period: Each group completed two 10-week consumption periods for each of the products, with an intermediate washing period of 4 weeks (28 days). |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2016-12-22
- Completion
- 2016-12-22
- First posted
- 2019-10-14
- Last updated
- 2019-10-17
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT04125199. Inclusion in this directory is not an endorsement.